Literature DB >> 19369702

Reactive oxygen species-independent oxidation of thioredoxin in hypoxia: inactivation of ribonucleotide reductase and redox-mediated checkpoint control.

Harish Muniyappa1, Shiwei Song, Christopher K Mathews, Kumuda C Das.   

Abstract

We have investigated the role of cellular redox state on the regulation of cell cycle in hypoxia and shown that whereas cells expressing mutant thioredoxin (Trx) or a normal level of Trx undergo increased apoptosis, cells overexpressing Trx are protected against apoptosis. We show that hypoxia activates p53 and Chk1/Chk2 proteins in cells expressing normal or mutant Trx but not in cells overexpressing Trx. We also show that the activity of ribonucleotide reductase decreases in hypoxia in cells expressing redox-inactive Trx. Although hypoxia has been shown to induce reactive oxygen species (ROS) generation in the mitochondria resulting in enhanced p53 expression, our data demonstrate that hypoxia-induced p53 expression and phosphorylation are independent of ROS. Furthermore, hypoxia induces oxidation of Trx, and this oxidation is potentiated in the presence of 6-aminonicotinamide, an inhibitor of glucose-6-phosphate dehydrogenase. Taken together our study shows that Trx redox state is modulated in hypoxia independent of ROS and is a critical determinant of cell cycle regulation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19369702      PMCID: PMC2719345          DOI: 10.1074/jbc.M109.008557

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

Review 1.  Cell cycle checkpoint signaling through the ATM and ATR kinases.

Authors:  R T Abraham
Journal:  Genes Dev       Date:  2001-09-01       Impact factor: 11.361

Review 2.  Post-translational modifications and activation of p53 by genotoxic stresses.

Authors:  E Appella; C W Anderson
Journal:  Eur J Biochem       Date:  2001-05

3.  Hyperoxia induces S-phase cell-cycle arrest and p21(Cip1/Waf1)-independent Cdk2 inhibition in human carcinoma T47D-H3 cells.

Authors:  J F Bilodeau; R Faure; B Piedboeuf; M E Mirault
Journal:  Exp Cell Res       Date:  2000-05-01       Impact factor: 3.905

Review 4.  Biological consequences of tumor hypoxia.

Authors:  M Höckel; P Vaupel
Journal:  Semin Oncol       Date:  2001-04       Impact factor: 4.929

5.  Redox regulation of p53 during hypoxia.

Authors:  N S Chandel; M G Vander Heiden; C B Thompson; P T Schumacker
Journal:  Oncogene       Date:  2000-08-10       Impact factor: 9.867

6.  G2 DNA damage checkpoint inhibition and antimitotic activity of 13-hydroxy-15-oxozoapatlin.

Authors:  N T Rundle; L Xu; R J Andersen; M Roberge
Journal:  J Biol Chem       Date:  2001-09-25       Impact factor: 5.157

7.  Hypoxia links ATR and p53 through replication arrest.

Authors:  Ester M Hammond; Nicholas C Denko; Mary Jo Dorie; Robert T Abraham; Amato J Giaccia
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

8.  c-Jun NH2-terminal kinase-mediated redox-dependent degradation of IkappaB: role of thioredoxin in NF-kappaB activation.

Authors:  K C Das
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

9.  Oxygen sensing and HIF-1 activation does not require an active mitochondrial respiratory chain electron-transfer pathway.

Authors:  V Srinivas; I Leshchinsky; N Sang; M P King; A Minchenko; J Caro
Journal:  J Biol Chem       Date:  2001-05-07       Impact factor: 5.157

10.  Molecular mechanisms of thioredoxin and glutaredoxin as hydrogen donors for Mammalian s phase ribonucleotide reductase.

Authors:  Farnaz Zahedi Avval; Arne Holmgren
Journal:  J Biol Chem       Date:  2009-01-28       Impact factor: 5.157

View more
  14 in total

Review 1.  p53 regulation of metabolic pathways.

Authors:  Eyal Gottlieb; Karen H Vousden
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-02       Impact factor: 10.005

Review 2.  Redox control systems in the nucleus: mechanisms and functions.

Authors:  Young-Mi Go; Dean P Jones
Journal:  Antioxid Redox Signal       Date:  2010-08-15       Impact factor: 8.401

3.  Thioredoxin-deficient mice, a novel phenotype sensitive to ambient air and hypersensitive to hyperoxia-induced lung injury.

Authors:  Kumuda C Das
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-12-24       Impact factor: 5.464

4.  Thioredoxin Activates MKK4-NFκB Pathway in a Redox-dependent Manner to Control Manganese Superoxide Dismutase Gene Expression in Endothelial Cells.

Authors:  Venkatesh Kundumani-Sridharan; Jaganathan Subramani; Kumuda C Das
Journal:  J Biol Chem       Date:  2015-05-31       Impact factor: 5.157

Review 5.  Targeting the p53 signaling pathway in cancer therapy - the promises, challenges and perils.

Authors:  Alexander H Stegh
Journal:  Expert Opin Ther Targets       Date:  2012-01-12       Impact factor: 6.902

6.  Thioredoxin reverses age-related hypertension by chronically improving vascular redox and restoring eNOS function.

Authors:  Rob H P Hilgers; Venkatesh Kundumani-Sridharan; Jaganathan Subramani; Leon C Chen; Luis G Cuello; Nancy J Rusch; Kumuda C Das
Journal:  Sci Transl Med       Date:  2017-02-08       Impact factor: 17.956

7.  c-Jun-NH2 terminal kinase (JNK)-mediates AP-1 activation by thioredoxin: phosphorylation of cJun, JunB, and Fra-1.

Authors:  Kumuda C Das; Harish Muniyappa
Journal:  Mol Cell Biochem       Date:  2009-10-27       Impact factor: 3.396

8.  Thioredoxin Uses a GSH-independent Route to Deglutathionylate Endothelial Nitric-oxide Synthase and Protect against Myocardial Infarction.

Authors:  Jaganathan Subramani; Venkatesh Kundumani-Sridharan; Rob H P Hilgers; Cade Owens; Kumuda C Das
Journal:  J Biol Chem       Date:  2016-09-01       Impact factor: 5.157

9.  Thioredoxin Decreases Anthracycline Cardiotoxicity, But Sensitizes Cancer Cell Apoptosis.

Authors:  Kumuda C Das; Harish Muniyappa; Venkatesh Kundumani-Sridharan; Jaganathan Subramani
Journal:  Cardiovasc Toxicol       Date:  2020-09-03       Impact factor: 3.231

10.  Balancing glycolytic flux: the role of 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatases in cancer metabolism.

Authors:  Susana Ros; Almut Schulze
Journal:  Cancer Metab       Date:  2013-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.